Form 4: Medpace Holdings Director Acquires Restricted Stock Units

Robert O. Kraft, a director at Medpace Holdings, acquired 227 restricted stock units on November 29, 2024.

Summary

• Robert O. Kraft, a director of Medpace Holdings, Inc., has reported the acquisition of 227 restricted stock units.
• The transaction occurred on November 29, 2024.
• These restricted stock units represent a contingent right to receive one share of MEDP common stock each.
• The units vest in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
• The price of the underlying common stock at the time of the transaction was $340.63.

Sentiment

Score: 7

Explanation: The transaction is a routine part of director compensation and indicates confidence in the company's future, but it is not a major event.

Positives

• The acquisition of restricted stock units by a director can be seen as a positive sign of confidence in the company's future performance.

Future Outlook

The restricted stock units will vest in four installments throughout 2025, potentially increasing the director's stake in the company.

Industry Context

This is a standard transaction for directors of publicly traded companies, often used as part of compensation packages to align their interests with those of shareholders.

Comparison to Industry Standards

• The vesting schedule of the restricted stock units is typical for executive compensation packages in the pharmaceutical and healthcare industry.
• Companies like ICON plc and IQVIA also use similar equity-based compensation for their directors and executives.
• The value of the stock units is consistent with the current market price of Medpace Holdings stock.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Medpace Holdings, Restricted Stock Units, Director, Robert O. Kraft, Stock Acquisition, MEDP, Insider Trading